Information Journal Paper
APA:
Copy. (2017). Cancer resistance to therapies against the EGFR-RAS-RAF pathway: the role of MEK. CANCER TREATMENT REVIEW, 53(-), 61-69. SID. https://sid.ir/paper/738549/en
Vancouver:
Copy. Cancer resistance to therapies against the EGFR-RAS-RAF pathway: the role of MEK. CANCER TREATMENT REVIEW[Internet]. 2017;53(-):61-69. Available from: https://sid.ir/paper/738549/en
IEEE:
Copy, “Cancer resistance to therapies against the EGFR-RAS-RAF pathway: the role of MEK,” CANCER TREATMENT REVIEW, vol. 53, no. -, pp. 61–69, 2017, [Online]. Available: https://sid.ir/paper/738549/en